These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 26027747

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Adenomatous lesions of the temporal bone immunohistochemical analysis and theories of histogenesis.
    Bold EL, Wanamaker JR, Hughes GB, Rhee CK, Sebek BA, Kinney SE.
    Am J Otol; 1995 Mar; 16(2):146-52. PubMed ID: 8572112
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Middle Ear and Temporal Bone Nonkeratinizing Squamous Cell Carcinomas With DEK-AFF2 Fusion: An Emerging Entity.
    Todorovic E, Truong T, Eskander A, Lin V, Swanson D, Dickson BC, Weinreb I.
    Am J Surg Pathol; 2020 Sep; 44(9):1244-1250. PubMed ID: 32366754
    [Abstract] [Full Text] [Related]

  • 5. Endolymphatic sac tumor (aggressive papillary tumor of middle ear and temporal bone): report of two cases with analysis of the VHL gene.
    Skalova A, Síma R, Bohus P, Curík R, Lukás J, Michal M.
    Pathol Res Pract; 2008 Sep; 204(8):599-606. PubMed ID: 18423895
    [Abstract] [Full Text] [Related]

  • 6. The effects of the novel, reversible epidermal growth factor receptor/ErbB-2 tyrosine kinase inhibitor, GW2016, on the growth of human normal and tumor-derived cell lines in vitro and in vivo.
    Rusnak DW, Lackey K, Affleck K, Wood ER, Alligood KJ, Rhodes N, Keith BR, Murray DM, Knight WB, Mullin RJ, Gilmer TM.
    Mol Cancer Ther; 2001 Dec; 1(2):85-94. PubMed ID: 12467226
    [Abstract] [Full Text] [Related]

  • 7. Middle ear adenoma with neuroendocrine differentiation.
    Gunduz M, Yamanaka N, Saito T, Kuki K, Yokoyama M, Nakamine H.
    Auris Nasus Larynx; 2000 Jan; 27(1):73-6. PubMed ID: 10648072
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Cancer of the middle ear and temporal bone.
    Conley JJ.
    N Y State J Med; 1974 Aug; 74(9):1575-9. PubMed ID: 4527067
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Adenomatous tumors of the middle ear.
    Pelosi S, Koss S.
    Otolaryngol Clin North Am; 2015 Apr; 48(2):305-15. PubMed ID: 25769353
    [Abstract] [Full Text] [Related]

  • 12. Angiotensin-converting enzyme 2 is a potential therapeutic target for EGFR-mutant lung adenocarcinoma.
    Yamaguchi M, Hirai S, Sumi T, Tanaka Y, Tada M, Nishii Y, Hasegawa T, Uchida H, Yamada G, Watanabe A, Takahashi H, Sakuma Y.
    Biochem Biophys Res Commun; 2017 Jun 03; 487(3):613-618. PubMed ID: 28433633
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Inverting papilloma of the temporal bone: case report and meta-analysis of risk factors.
    Shen J, Baik F, Mafee MF, Peterson M, Nguyen QT.
    Otol Neurotol; 2011 Sep 03; 32(7):1124-33. PubMed ID: 21817933
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.